Home / Products / API / Agomelatine

loading

facebook sharing button
twitter sharing button
line sharing button
wechat sharing button
linkedin sharing button
pinterest sharing button
sharethis sharing button
Model: Nutritional Supplement
Brand: KSW
Product Name: Agomelatine
Molecular Weight: 243.301 g/mol
Molecular Formula: C15H17NO2
CAS Number: 138112-76-2
Availability:
Quantity:

Agomelatine

Use of Agomelatine
Agomelatine is a competitive antagonist of human and porcine serotonin (5-HT2C) receptors (pKi = 6.2 and 6.4, respectively) as well as human 5-HT2B receptors (pKi = 6.6). IC50 value: 6.2 (pKi, 5-HT2c); 6.6 (pKi, 5-HT2b)Target: 5-HT2C Receptor; 5-HT2B receptorIt is classified as a norepinephrine-dopamine disinhibitor (NDDI) due to its antagonism of the 5-HT2C receptor. Activation of 5-HT2C receptors by serotonin inhibits dopamine and norepinephrine release. Antagonism of 5-HT2C results in an enhancement of DA and NE release and activity of frontocortical dopaminergic and adrenergic pathways. Agomelatine is also a potent agonist at melatonin receptors which makes it the first melatonergic antidepressant. Agomelatine is an antidepressant drug.
Properties
Articles48
Spectrum
Product Description
Common Name Agomelatine
CAS Number 138112-76-2 Molecular Weight 243.301
Density 1.1±0.1 g/cm3 Boiling Point 478.8±28.0 °C at 760 mmHg
Molecular Formula C15H17NO2 Melting Point 107-109ºC
MSDS ChineseUSA Flash Point 243.4±24.0 °C
Symbol GHS09
GHS09
Signal Word Warning
Description Agomelatine is a competitive antagonist of human and porcine serotonin (5-HT2C) receptors (pKi = 6.2 and 6.4, respectively) as well as human 5-HT2B receptors (pKi = 6.6). IC50 value: 6.2 (pKi, 5-HT2c); 6.6 (pKi, 5-HT2b)Target: 5-HT2C Receptor; 5-HT2B receptorIt is classified as a norepinephrine-dopamine disinhibitor (NDDI) due to its antagonism of the 5-HT2C receptor. Activation of 5-HT2C receptors by serotonin inhibits dopamine and norepinephrine release. Antagonism of 5-HT2C results in an enhancement of DA and NE release and activity of frontocortical dopaminergic and adrenergic pathways. Agomelatine is also a potent agonist at melatonin receptors which makes it the first melatonergic antidepressant. Agomelatine is an antidepressant drug.
Related Catalog
References

[1]. Pan L, Kardono LB, Riswan S, Chai H, Carcache de Blanco EJ, Pannell CM, Soejarto DD, McCloud TG, Newman DJ, Kinghorn AD.Isolation and characterization of minor analogues of silvestrol and other constituents from a large-scale re-collection of Aglaia foveolata.J Nat Prod. 2010 Nov 29;73(11):1873-8.

[2]. Zajecka J, Schatzberg A, Stahl S. et al. Efficacy and safety of agomelatine in the treatment of major depressive disorder: a multicenter, randomized, double-blind, placebo-controlled trial. J Clin Psychopharmacol. 2010 Apr;30(2):135-44.

[3]. Randy A Sansone, Lori A Sansone. Agomelatine A Novel Antidepressant. Innov Clin Neurosci. 2011 November; 8(11): 10-14.

[4]. Michele Fornaro, Davide Prestia, Salvatore Colicchio, and Giulio Perugi. A Systematic, Updated Review on the Antidepressant Agomelatine Focusing on its Melatonergic Modulation. Curr Neuropharmacol. 2010 September; 8(3): 287-304.

[5]. Agomelatine

Density 1.1±0.1 g/cm3
Boiling Point 478.8±28.0 °C at 760 mmHg
Melting Point 107-109ºC
Molecular Formula C15H17NO2
Molecular Weight 243.301
Flash Point 243.4±24.0 °C
Exact Mass 243.125931
PSA 38.33000
LogP 2.27
Vapour Pressure 0.0±1.2 mmHg at 25°C
Index of Refraction 1.582
Storage condition -20°C Freezer


Previous: 
Next: